Latest article
Metavention Declares Initiation of U.S. Scientific Trial for Novel Remedy of Sort 2 Diabetes
MINNEAPOLIS, February 17, 2021 / PRNewswire / - Metavention, Inc. announces the initiation of an FDA-cleared clinical investigation, DeLIVER (NCT04285554), for the company's iRF...
